ENSG00000143627


Homo sapiens

Features
Gene ID: ENSG00000143627
  
Biological name :PKLR
  
Synonyms : P30613 / PKLR / pyruvate kinase L/R
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 1
Strand: -1
Band: q22
Gene start: 155289293
Gene end: 155301434
  
Corresponding Affymetrix probe sets: 207858_s_at (Human Genome U133 Plus 2.0 Array)   210451_at (Human Genome U133 Plus 2.0 Array)   222078_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000339933
Ensembl peptide - ENSP00000376214
Ensembl peptide - ENSP00000398037
Ensembl peptide - ENSP00000496762
NCBI entrez gene - 5313     See in Manteia.
OMIM - 609712
RefSeq - XM_017001493
RefSeq - NM_000298
RefSeq - NM_181871
RefSeq - XM_006711386
RefSeq - XM_011509640
RefSeq Peptide - NP_000289
RefSeq Peptide - NP_870986
swissprot - P30613
swissprot - F8W6W2
Ensembl - ENSG00000143627
  
Related genetic diseases (OMIM): 102900 - Adenosine triphosphate, elevated, of erythrocytes, 102900
  266200 - Pyruvate kinase deficiency, 266200
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 pklrENSDARG00000042010Danio rerio
 PklrENSMUSG00000041237Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
PKM / P14618 / pyruvate kinase M1/2ENSG0000006722564


Protein motifs (from Interpro)
Interpro ID Name
 IPR001697  Pyruvate kinase
 IPR011037  Pyruvate kinase-like, insert domain superfamily
 IPR015793  Pyruvate kinase, barrel
 IPR015795  Pyruvate kinase, C-terminal
 IPR015813  Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily
 IPR018209  Pyruvate kinase, active site
 IPR036918  Pyruvate kinase, C-terminal domain superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0001666 response to hypoxia IEA
 biological_processGO:0005975 carbohydrate metabolic process IEA
 biological_processGO:0006096 glycolytic process IEA
 biological_processGO:0006754 ATP biosynthetic process IEA
 biological_processGO:0007584 response to nutrient IEA
 biological_processGO:0008152 metabolic process IEA
 biological_processGO:0009408 response to heat IEA
 biological_processGO:0009749 response to glucose IEA
 biological_processGO:0010038 response to metal ion IEA
 biological_processGO:0010226 response to lithium ion IEA
 biological_processGO:0016310 phosphorylation IEA
 biological_processGO:0032869 cellular response to insulin stimulus IBA
 biological_processGO:0033198 response to ATP IEA
 biological_processGO:0042866 pyruvate biosynthetic process IEA
 biological_processGO:0051591 response to cAMP IEA
 biological_processGO:0061621 canonical glycolysis TAS
 biological_processGO:0071872 cellular response to epinephrine stimulus IEA
 cellular_componentGO:0005737 cytoplasm IBA
 cellular_componentGO:0005829 cytosol TAS
 cellular_componentGO:0070062 extracellular exosome HDA
 molecular_functionGO:0000166 nucleotide binding IEA
 molecular_functionGO:0000287 magnesium ion binding IEA
 molecular_functionGO:0003824 catalytic activity IEA
 molecular_functionGO:0004743 pyruvate kinase activity IEA
 molecular_functionGO:0005524 ATP binding IEA
 molecular_functionGO:0016301 kinase activity IEA
 molecular_functionGO:0016740 transferase activity IEA
 molecular_functionGO:0030955 potassium ion binding IEA
 molecular_functionGO:0046872 metal ion binding IEA


Pathways (from Reactome)
Pathway description
No match


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000952 Jaundice "Yellow pigmentation of the skin or sclera due to bilirubin, which in turn is the result of increased bilirubin concentration in the bloodstream." [HPO:curators]
Show

 HP:0001081 Cholelithiasis 
Show

 HP:0001082 Cholecystitis 
Show

 HP:0001511 Intrauterine growth retardation 
Show

 HP:0001560 Abnormality of the amniotic fluid "Abnormality of the amniotic fluid, which is the fluid contained in the amniotic sac surrounding the developing fetus." [HPO:curators]
Show

 HP:0001744 Splenomegaly "An abnormal enlargement of the spleen." [HPO:curators]
Show

 HP:0001789 Hydrops fetalis 
Show

 HP:0001790 Nonimmune hydrops fetalis 
Show

 HP:0001901 Erythrocytosis 
Show

 HP:0001923 Reticulocytosis 
Show

 HP:0003281 Increased serum ferritin 
Show

 HP:0003452 Increased serum iron 
Show

 HP:0004447 Poikilocytosis 
Show

 HP:0004804 congenital hemolytic anemia 
Show

 HP:0004870 chronic hemolytic anemia 
Show

 HP:0005502 Increased red cell osmotic fragility 
Show

 HP:0006579 Prolonged neonatal jaundice 
Show

 HP:0008282 Unconjugated hyperbilirubinemia 
Show

 HP:0011273 Anisocytosis "Abnormally increased variability in the size of erythrocytes." [HPO:probinson]
Show

 HP:0012463 Elevated transferrin saturation "An above normal level of saturation of serum transferrin with iron." [HPO:probinson]
Show

 HP:0025109 Reduced red cell pyruvate kinase activity "Decrease in the activity of pyruvate kinase (PK) within erythrocytes. PK catalyzes the reaction: ATP + pyruvate = ADP + phosphoenolpyruvate." [PMID:7949104]
Show

 HP:0030271 Reduced erythrocyte 2,3-diphosphoglycerate concentration "2,3-diphosphoglycerate (2,3-DPG) controls the movement of oxygen from red blood cells to tissues. Anemia is usually accompanied by an increased level of 2,3-DPG in order to promote tissue oxygenation. This term refers to an inappropriate low 2,3-DPG concentration in erythrocytes." [HPO:probinson]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000143627 PKLR / P30613 / pyruvate kinase L/R  / complex






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr